✦ LIBER ✦

Three-year Experience with Alendronate Treatment in Postmenopausal Osteoporotic Japanese Women with or without Renal Dysfunction

✍ Scribed by Dr Jun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, Tsuyoshi Takeda…

Book ID: 120806414
Publisher: Springer International Publishing AG
Year: 2012
Tongue: English
Weight: 181 KB
Volume: 29
Category: Article
ISSN: 1170-229X
DOI: 10.2165/11598440-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Three-year experience with alendronate t

Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without type 2 diabetes

✍ Jun Iwamoto; Yoshihiro Sato; Mitsuyoshi Uzawa; Tsuyoshi Takeda; Hideo Matsumoto 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 451 KB

Effects of one year daily teriparatide t

Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate

✍ Sonja Gamsjaeger; Birgit Buchinger; Ruth Zoehrer; Roger Phipps; Klaus Klaushofer 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 468 KB

Effects of one year daily teriparatide t

Effects of one year daily teriparatide treatment on iliac bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women treated prior with alendronate or risedronate

✍ B.M. Misof; E.P. Paschalis; R. Zoehrer; S. Blouin; N. Fratzl-Zelman; R. Phipps; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Three-year study of estrogen alone versu

Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia

✍ Mitsuhiro Sanada; Hitoshi Nakagawa; Ichiro Kodama; Tomohisa Sakasita; Koso Ohama 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 564 KB

Effects of 1 year of daily teriparatide

Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate

✍ Barbara M Misof; Eleftherios P Paschalis; Stéphane Blouin; Nadja Fratzl-Zelman; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 163 KB 👁 1 views

## Abstract Anabolic treatment with teriparatide of postmenopausal osteoporotic patients previously treated with bisphosphonates is a new therapeutic approach. However, its effects on the bone mineralization density distribution (BMDD) are unknown. We studied paired transiliac bone biopsy samples t